Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle?
An activist investor made a strong argument for walking away from Celgene, but will investors listen?...
Related Articles
- Jamie Dimon's Power Struggle: Loses Bank Chairman Role, A Bigger Blow May Come Next also categorized in BoardBlogs
- Why Jos. A. Bank Fights For Men's Wearhouse also categorized in BoardBlogs
- Proxy Advisory Services: Making Glass (Lewis) Transparent -- And ISS Too also categorized in BoardBlogs
- 3 AIM Shares With Good Corporate Governance: Part 1 also published in Fool.com
- Third Point Capital's Dan Loeb Talks About Sony; Olympus Rising also categorized in BoardBlogs
- The Power Of Investors When It Comes To Honing Corporate Governance also categorized in BoardBlogs
- The Men Who Run Glencore also published in Fool.com
- Public Companies' Public Enemies also published in Fool.com
- EYVoice: Why You Should Act Like An IPO While You're Still Private also categorized in BoardBlogs
- 'The Real Opportunity On Diversity Is To Be More Thoughtful' also categorized in BoardBlogs
Login to comment.